chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever upto 38.9 degree Celsius; Initial information was received on 16-Jan-2021 regarding an unsolicited valid non-serious case from Physician via Health Authorities under reference 2021030767.  This case involves a male patient who experienced fever up to 38.9 degree Celsius (pyrexia), while he received vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  Medical history, medical treatments, past vaccinations, concomitant medication and family history were not provided. At the time of the event, the patient had ongoing Food allergy and Drug hypersensitivity.   On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE (Suspension for injection, lot number and expiration not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious fever up to 38.9 degree Celsius (pyrexia), (unknown latency) following the administration of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE.  Relevant laboratory test results included: Body temperature was 38.9 degree Celsius on an unknown date.  It was not reported if the patient received any corrective treatment or not.  The patient was recovered from the fever on an unknown date.  The reporter assessed the causal relationship for event with the DAPTACEL as related.  There will be no information on the batch number for this case.
bumps on lymph node; This is a spontaneous report received from a contactable consumer (patient). A 44 years old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) first dose on 03Mar2021 via an unspecified route of administration as single dose for COVID-19 immunisation. Patient medical history and concomitant medication were not reported. Patient stated that she was due to receive second dose but was reporting bumps on lymph node on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Complained of throat itching and difficulty swallowing, facial swelling and lips itchy and feeling swollen.
Symptoms include: decreased appetite, nausea, inability to eat, fatigue, and weakness. Positive COVID-19 results on 2/1/22. Treatment includes: IV and oral fluids, therapy, monitor fluid status, and telemetry.
On January 25 I noticed a rash/hives on my chest and abdomen area.  It has been almost 24 hours and they have not resolved.  The severity is about a 3 out of 10, they have remained localized and are only mildly itchy.  I have no other symptoms and I have not altered my daily routine or interacted with anything which could explain the hives.  I have not been ill for over 6 months but the rash reminds me of after recovering from a virus when it is shedding.  I spoke with a healthcare provider and he suggested I file a report.
joint pain; This case was reported by a consumer via interactive digital media and described the occurrence of joint pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced joint pain. On an unknown date, the outcome of the joint pain was unknown.   It was unknown if the reporter considered the joint pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had joint pain. The reporter asked f it could be a side effect of the 2nd Shingrix.
I had persistent cough and cold symptoms for the week after; I had persistent cough and cold symptoms for the week after; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 11Sep2021 12:45 (Batch/Lot number: unknown) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: METOPROLOL. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. , Lot unknown reason: Not available/provided to reporter at the time of report completion, Vaccine Administration Time: 12:30 PM), administration date: 21Aug2021, when the patient was 37 years old, for Covid-19 immunization. The following information was reported: COUGH (non-serious), NASOPHARYNGITIS (non-serious) all with onset 12Sep2021, outcome "recovered with sequelae" (2021) and all described as "I had persistent cough and cold symptoms for the week after". Therapeutic measures were not taken as a result of cough, nasopharyngitis.  Additional information:lot unknown reason=Not available/provided to reporter at the time of report completion.if other vaccine in fourweeks: No.other medications in two weeks: 25 mg metoprolol.ae resulted in: None of the above.if patient recovered: Recovered with lasting effects.if covid prior vaccination: No. if covid tested post vaccination: No.known allergies:No.other medical history: No.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PREVNAR administered 6/17/15. Tenderness and redness by 6/18/15. Worsening redness, swelling, warmth to touch to deltoid area.
The pt developed minor swelling of arm. Swelling progressed into shoulder into neck. Left leg also swollen.
Severe stabbing headaches night of vaccination, sense of brain trauma. Repeated headaches one week late, on 10/10/07, and on subsequent days through today (10/13)/07, with additional symptoms of light-headedness and nausea
Right axillary lymphadenopathy and LN pain. Also moderate subcutaneous non-pitting edema of right axilla. Mild pyrexia and fatigue.
Loss of appetite; dizziness, stiff joints in ankles, wrists, elbows, jaw, lower back; flushed face lasting 3 days; elevated blood pressure ranging from 150 to 160; weakness... slept for 36 hours; fever of 101 degrees; most averse reactions last 3 full days. Comment on item 17... no other vaccines given besides the SHINGRIX.
received their 1st dose of Pfizer and came in today and got the Moderna; inappropriate age; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received their 1st dose of Pfizer and came in today and got the Moderna) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received their 1st dose of Pfizer and came in today and got the Moderna) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (received their 1st dose of Pfizer and came in today and got the Moderna) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided
Nausea/vomiting, tingling lips, tongue, throat, difficulty swallowing. Went to the ER and received 2 rounds of epi, IVP benadryl, solu medrol, pepcid, and a liter of fluid.  Rebound reaction 7/28 difficulty breathing, difficulty swallowing, tingling lips and in throat. Epipen used and then in the ER recieved another epi, IV steriods, benadryl, pepcid, liter of fluids, and a breathing treatment.
breakthrough case; breakthrough case; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (115193). The reporter is the patient.  A 36 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 36 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2021, outcome "unknown" and all described as "breakthrough case". Patient reported that, he had a breakthrough case in fall 2021. He stated that his only symptom was a lack of smell and that he got tested after being unable to smell his baby's diaper, No additional information reported at this time.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fatigue but only in evening. Able to work. Irregular heart beat (not normal intermittent PVC) that caused chest discomfort. Nothing concerning, just more curious. With second vaccine, developed chills within one hour and went to bed. Upon awakening, had headache, nausea, chills, kidney area pain, chest discomfort from irregular heart beat. This resolved for about 18 hours, then started again and lasted for 1 week. Chest pain became sharp at times  spreading to arm with mild shortness of breath. Having had a full heart workup last year, did not pursue tests. wanted to see if would pass on it's own. After one week, only have occasional chest discomfort. Arrhythmia has returned to baseline occasional PVC. No further chills, headache, nausea or other pains.
I know 3 people died because of the vaccine; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported same event for 3 patients. This report is for 2nd of 3 patients.   This consumer reported that a patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. Reporter was reading a letter from FDA dated 23Aug2021, asking for the ingredients of COMIRNATY. The reporter asked when was Comirnaty going to be available and why was it already FDA approved then it was not available right now It's scary because people are dying because of the vaccine. Reporter knew 3 people died because of the vaccine. Reporter also mentioned she was concerned about the liability of Pfizer since the available one was the Pfizer Biontech COVID 19 vaccine. Reporter was unsure if it was Pfizer. It was unknown if Autopsy Done. The outcome of the event was fatal.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101265404 same drug,AE, different patient;US-PFIZER INC-202101266048 same drug,AE, different patient; Reported Cause(s) of Death: I know 3 people died because of the vaccine
Significant soreness in arm at injection site for about 3-4 days.  Swollen and red at injection site for 1-2 days.  Flu type symptoms started about 24 hours after injection and lasted for a day.
14 days after the 2nd dose terrible hives, blisters and sever itch lasting more than 8 days so far.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 57 year old male. The patient's height, and weight were not reported. The patient's past medical history included: pneumonia (30 years ago had pneumonia real bad like for a year), and concurrent conditions included: ex-smoker (Quit smoking). The patient had no history and was pretty healthy overall. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 205A21A expiry: unknown) dose was not reported, 1 in total was administered on 03-MAY-2021 to right arm for covid-19 prophylaxis. Age at time of vaccination 56 years old. No concomitant medications were reported. The patient received non-company booster of Pfizer biontech covid-19 vaccine (tozinameran) (dose number in series 2) (form of administration, route of administration, batch number were not reported, expiry: unknown), dose was not reported, administered on 07-NOV-2021 for covid-19 prophylaxis.  It was unknown whether the patient had any adverse events following vaccination with Pfizer biontech covid-19 vaccine (tozinameran) (dose number in series 2).  The patient additionally received second booster dose of covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 3) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. It was reported that on 03-AUG-2022, the patient tested positive for covid-19 and also mentioned on the same day, a little earlier the symptoms had begun. The patient mentioned the symptoms was just not feeling well (coded as confirmed covid-19 infection and confirmed clinical vaccination failure). Laboratory data included: covid-19 virus test positive (dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000244954. This case, involving the same patient is linked to 20220823011.; Sender's Comments: V0: 20220807187- covid-19 vaccine ad26.cov2.s - confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Began with hives and itching lower back and center back.   A few days later, law line and neck had hives and itching.  Four days ago, cheeks were swollen with welps, entire face rash and itching.   Today, April 12, hives on back comes and goes and the rash and itching on my face and neck comes and goes.  The symptoms are not gone and recur especially when I get hot or when I take a hot bath/shower.
Injection site inflammation; This spontaneous case was reported by a physician assistant (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE INFLAMMATION (Injection site inflammation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (Injection site inflammation). The patient was treated with DEXAMETHASONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INFLAMMATION (Injection site inflammation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Patient had redness and swelling and was told by the Nurse Prac that her body reacted to the site and led to cellulitis, Had extensive redness and swelling that itched. Benadryl  gave no relief, pt already had appt for more immunizations on 6.10.19 and sought prescriber guidance.
Swelling of arms, patches of redness on arms, pain in arms, headache, dissiness, disoriented, fever (103.7).
my symptoms of dermatographia have fully returned; itchy; welts; hives; This is a spontaneous report from a contactable consumer (patient reported for himself).   A 28-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0167) via an unspecified route of administration, in left arm on 06May2021 14:00 (at the age of 28-years-old) as dose 2, single for covid-19 immunization. The patient medical history included dermatographia. Patient previously took amoxicillin and had experienced allergy. Patient was known allergic to penicillin. The patient concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0164) via an unspecified route of administration, in left arm on 15Apr2021 14:00 (at the age of 28-years-old) as dose 1, single for covid-19 immunization. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient had not received any other vaccine in four weeks. Patient reported that he previously had dermatographia growing up, all symptoms and issues have been resolved for the past 5 years (ending when he was 23 years of age). Patient reported upon receiving his 2nd Pfizer vaccination, his symptoms of dermatographia have fully returned on 06May2021 at 20:00, that included itchy welts and hives that occurred from physical contact (scratching his skin, colliding with an object, abrasion from his pillow when he slept, etc). These symptoms have been going for a little over a month now without easing up. Patient did not receive any treatment for the events. Outcome of the events were not recovered.  Follow-up attempts are completed. No further information is expected.
Information has been received from a medical assistant referring to two unspecified patients of unknown age and gender. The patients' medical history, concomitant therapy and concurrent condition were not provided. Since 20-SEP-2016, 2 doses of improperly-stored doses of varicella virus vaccine live (dose and route were unknown; lot number was L050957 with expiration date 17-DEC-2017) were administered to two unspecified patients on unspecified dates. No adverse experience was reported. The temperature excursion was -3 centigrade degree for 2 hours and 15 minutes. There was no previous temperature excursion. This report was for data logger. Additional information has been requested.
Swelling glands at neck, chest, groin, and under arm; JOINT PAIN; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (JOINT PAIN) and LYMPHADENOPATHY (Swelling glands at neck, chest, groin, and under arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L2OA) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from March 2020 to April 2020.    On 10-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced ARTHRALGIA (JOINT PAIN). On 11-Jan-2021, the patient experienced LYMPHADENOPATHY (Swelling glands at neck, chest, groin, and under arm). At the time of the report, ARTHRALGIA (JOINT PAIN) and LYMPHADENOPATHY (Swelling glands at neck, chest, groin, and under arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Blood test: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.
A few hours after the shot I began feeling anxious, shortness of breath, tense. This tapered off somewhat later in the night. I went to bed ~11:30 and then woke up about 2:00 AM again tense and short of breath.  I've been having a level of this condition since.   The last 3 days I've been taking Allegra 24 hr (180mg) thinking it might be allergies but haven't notice much improvement.
Fever; Chills; Sleeplessness around 4-21 @ 12AM.; Nausea day of; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Apr2021 at 09:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 09:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 17:00, the patient experienced nausea day of vaccination. Around 21Apr2021 at 00:00, the patient experienced fever, chills and sleeplessness. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea day of, fever, chills and sleeplessness were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
BODY ACHES, CHILLS, Narrative:  SX LASTED 2 DAYS  Other Relevant History:
Pt received immunization in R deltoid - developed rash/hives to arm, chest and back. BENADRYL 25 mg po x1  administered; transported to ED.
Patient felt lightheaded (felt like sinus pressure) with tachycardia (heart rate ranged from 90-122 bpm).
Symptoms: fever at 101F, serous left arm pain, serious headache. Starting time: 15 hours after vaccination. Treatment: 1 pill 200mg ibuprofen, 18 hours after vaccination Outcome: fever ends 22 hours after vaccination, headache ends 26 hours after vaccination, left arm pain ends 60 hours after vaccination.
Shot 2- 4/15/21- Thursday   6 hours after- nausea started   9 PM ? extremely nauseous, uncontrollable chills, 102 fever and skin hurt to touch (that didn?t last long)  (Friday)Next morning- low-grade fever, mild headache, no appetite  2 pm- still no appetite, headache, neck pain and chills  Bedtime- chills, low-grade fever   Saturday- 4/17- woke up completely soaked- I?m thinking I must?ve spiked a fever during the night. I also woke up with sharp painful chest pain. Went to the ER my D dimer blood tests were slightly elevated so they did a CAT scan and didn?t find any evidence of blood clots.  Saturday Evening- still no appetite, headache and neck pain   Today -4/18- still no appetite,neck pain,headache and fatigue
Patient was found after receiving this dose of the flu vaccine to have already received the flu vaccine in October 2022.Vaccines were given in flu Blitz , so their past list was only pulled after the Blitz. Consent was provided by the parents, who would have known if the patient had already received the vaccine.  No noted adverse effects have been noted from getting the second dose, it has been over 17 hours since dose was given. Medical team made aware of incident.